January 31, 2026
January 31, 2026
Categories

The January 2026 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
January 29, 2026
January 29, 2026
Categories

Press Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer

Do you like it?
Read more
January 21, 2026
January 21, 2026
Categories

ECOG-ACRIN study identifies high rates of vulnerability in AML patients aged 60 years or older

Do you like it?
Read more
January 8, 2026
January 8, 2026
Categories

WATCH: Drs. Jen Specht and Heather Jacene discuss the FEATURE (EA1183) trial results…a game-changer for bone-dominant metastatic breast cancer

Do you like it?
Read more
January 8, 2026
January 8, 2026
Categories

AI models advance individualized breast cancer recurrence risk assessments

Do you like it?
Read more
January 8, 2026
January 8, 2026
Categories

Caris, cooperative groups advancing AI models that can improve breast cancer risk assessments (access requires free registration)

Do you like it?
Read more
January 8, 2026
January 8, 2026
Categories

WATCH: Dr. Joe Sparano discusses a new AI tool for breast cancer recurrence screening

Do you like it?
Read more
January 4, 2026
January 4, 2026
Categories

JAMA publishes ALCHEMIST EA5142 results: Nivolumab does not further reduce risk of recurrence in non-small cell lung cancer patients who completed standard post-surgery treatment

Do you like it?
Read more
ECOG-ACRIN Cancer Research Group